224 related articles for article (PubMed ID: 11949964)
1. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis.
Chwalisz K; Garg R; Brenner RM; Schubert G; Elger W
Ann N Y Acad Sci; 2002 Mar; 955():373-88; discussion 389-93, 396-406. PubMed ID: 11949964
[TBL] [Abstract][Full Text] [Related]
2. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
Bouchard P; Chabbert-Buffet N; Fauser BC
Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
[TBL] [Abstract][Full Text] [Related]
3. [Selective progesterone receptor modulators and their therapeutical use].
Driák D; Sehnal B; Svandová I
Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
[TBL] [Abstract][Full Text] [Related]
4. Investigational developments for the treatment of progesterone-dependent diseases.
Möller C; Hoffmann J; Kirkland TA; Schwede W
Expert Opin Investig Drugs; 2008 Apr; 17(4):469-79. PubMed ID: 18363513
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
6. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.
Olive DL
Obstet Gynecol Surv; 2002 Nov; 57(11 Suppl 4):S55-63. PubMed ID: 12454529
[TBL] [Abstract][Full Text] [Related]
7. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
[TBL] [Abstract][Full Text] [Related]
8. Elagolix as a Novel Treatment for Endometriosis-Related Pain.
Fantasia HC
Nurs Womens Health; 2019 Aug; 23(4):366-369. PubMed ID: 31276630
[TBL] [Abstract][Full Text] [Related]
9. [Interest of selective progesterone receptor modulators in endometriosis].
Merviel P; Lourdel E; Sanguin S; Gagneur O; Cabry R; Nasreddine A
Gynecol Obstet Fertil; 2013 Sep; 41(9):524-8. PubMed ID: 23972920
[TBL] [Abstract][Full Text] [Related]
10. Next step in the development of mesoprogestins: the preclinical profile of EC313.
Błaszczak-Świątkiewicz K; Krupa A; Mnich E; Elger W; Oettel M; Nair H; Wierzbicki M; Sieroszewski P; Shaked Z
Front Endocrinol (Lausanne); 2023; 14():1201547. PubMed ID: 37766684
[TBL] [Abstract][Full Text] [Related]
11. [Treatment for endometriosis].
Olartecoechea B; García Manero M; Royo P; Aubà M
Rev Med Univ Navarra; 2009; 53(3):12-4. PubMed ID: 19994769
[TBL] [Abstract][Full Text] [Related]
12. [Selective progesterone receptor modulators: future clinical applications].
Bouchard P; Ouzounian S; Chabbert-Buffet N
Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
[TBL] [Abstract][Full Text] [Related]
13. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
[TBL] [Abstract][Full Text] [Related]
14. The immninent dawn of SPRMs in obstetrics and gynecology.
Chabbert-Buffet N; Pintiaux A; Bouchard P
Mol Cell Endocrinol; 2012 Jul; 358(2):232-43. PubMed ID: 22415029
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs for endometriosis.
Chlouber RO; Olive DL; Pritts EA
Expert Opin Investig Drugs; 2006 Apr; 15(4):399-407. PubMed ID: 16548789
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs).
Spitz IM
Semin Reprod Med; 2005 Feb; 23(1):3-7. PubMed ID: 15714385
[No Abstract] [Full Text] [Related]
17. Endometriosis association research center.
Begum B; Uddin MK; Afroz L; Begum K; Shakoor MA
Mymensingh Med J; 2005 Jul; 14(2):223-7. PubMed ID: 16056218
[TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological therapies for the treatment of endometriosis.
Buggio L; Dridi D; Barbara G; Merli CEM; Cetera GE; Vercellini P
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1039-1052. PubMed ID: 36000243
[TBL] [Abstract][Full Text] [Related]
19. Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs).
Chwalisz K; Garg R; Brenner R; Slayden O; Winkel C; Elger W
Reprod Biol Endocrinol; 2006; 4 Suppl 1(Suppl 1):S8. PubMed ID: 17118172
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
Wardell SE; Edwards DP
Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
